Epigenetics Group

Guro E. Lind
Guro E. Lind

We focus our research on the cancer epigenome and DNA methylation in particular. By integrating large-scale analyses with detailed candidate gene characterization we aim at identifying DNA methylation biomarkers with clinical impact.

The group is an associated member of the Centre for Excellence in Cancer Biomedicine.

 

Diseases we research

Colorectal cancer

Bladder cancer

Cholangiocarcinoma

 

Topics we research

Epigenetic biomarkers for early detection and monitoring

Epigenetic master keys in cancer development

Analyzing the underlying biology and clinical potential of DNA methylation supernegative cancers

 

Download

PoDCall – Bioconductor

 

 

  KG Jebsen Research Centre for Colorectal Cancer

 

Contact information

Department of Molecular Oncology, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 22781729 / +47 48022525
E mail: guro.elisabeth.lind@rr-research.no

 

Scroll to top